» Articles » PMID: 7537590

Inhibition of Carrageenin-induced Rat Paw Oedema by Crotapotin, a Polypeptide Complexed with Phospholipase A2

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1995 Feb 1
PMID 7537590
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

1. The effect of purified crotapotin, a non-toxic non-enzymatic chaperon protein normally complexed to a phospholipase A2 (PLA2) in South America rattlesnake venom, was studied in the acute inflammatory response induced by carrageenin (1 mg/paw), compound 48/80 (3 micrograms/paw) and 5-hydroxytryptamine (5-HT) (3 micrograms/paw) in the rat hind-paw. The effects of crotapotin on platelet aggregation, mast cell degranulation and eicosanoid release from guinea-pig isolated lung were also investigated. 2. Subplantar co-injection of crotapotin (1 and 10 micrograms/paw) with carrageenin or injection of crotapotin (10 micrograms/paw) into the contralateral paw significantly inhibited the carrageenin-induced oedema. This inhibition was also observed when crotapotin (10-30 micrograms/paw) was administered either intraperitoneally or orally. Subplantar injection of heated crotapotin (15 min at 60 degrees C) failed to inhibit carrageenin-induced oedema. Subplantar injection of crotapotin (10 micrograms/paw) also significantly inhibited the rat paw oedema induced by compound 48/80, but it did not affect 5-HT-induced oedema. 3. In adrenalectomized animals, subplantar injection of crotapotin markedly inhibited the oedema induced by carrageenin. The inhibitory effect of crotapotin was also observed in rats depleted of histamine and 5-HT stores. 4. Crotapotin (30 micrograms/paw) had no effect on either the histamine release induced by compound 48/80 in vitro or on the platelet aggregation induced by both arachidonic acid (1 nM) and platelet activating factor (1 microM) in human platelet-rich plasma. The platelet aggregation and thromboxane B2 (TXB2) release induced by thrombin (100 mu ml-1) in washed human platelets were also not affected by crotapotin. In addition, crotapotin (10 microg/paw) did not affect the release of 6-oxo-prostaglandin Fla, and TXB2 induced by ovalbumin in sensitized guinea-pig isolated lungs.5. Our results indicate that the anti-inflammatory activity of crotapotin is not due to endogenous corticosteroid release or inhibition of cyclo-oxygenase activity. It is possible that crotapotin may interact with extracellular PLA2 generated during the inflammatory process thereby reducing its hydrolytic activity.

Citing Articles

Fraction of venom containing crotapotin protects PC12 cells against MPP toxicity by activating the NGF-signaling pathway.

Bernardes C, Lopes Pinheiro E, Ferreira I, Oliveira I, Dos Santos N, Sampaio S J Venom Anim Toxins Incl Trop Dis. 2024; 30:e20230056.

PMID: 38915449 PMC: 11194915. DOI: 10.1590/1678-9199-JVATITD-2023-0056.


Biological and Medical Aspects Related to South American Rattlesnake (Linnaeus, 1758): A View from Colombia.

Canas C Toxins (Basel). 2022; 14(12).

PMID: 36548772 PMC: 9784998. DOI: 10.3390/toxins14120875.


The anti-inflamatory effect of Andira anthelmia lectin in rats involves inhibition of the prostanoid pathway, TNF-α and lectin domain.

Nascimento F, Freitas Pires A, Mota M, Isaias P, Araujo D, de Queiroz Martins M Mol Biol Rep. 2022; 49(9):8847-8857.

PMID: 35882745 DOI: 10.1007/s11033-022-07735-0.


Crotoxin-Induced Mice Lung Impairment: Role of Nicotinic Acetylcholine Receptors and COX-Derived Prostanoids.

Sartim M, Souza C, Diniz C, da Fonseca V, Sousa L, Peti A Biomolecules. 2020; 10(5).

PMID: 32443924 PMC: 7277605. DOI: 10.3390/biom10050794.


Immunotherapeutic potential of Crotoxin: anti-inflammatory and immunosuppressive properties.

Sartim M, Menaldo D, Sampaio S J Venom Anim Toxins Incl Trop Dis. 2018; 24:39.

PMID: 30564276 PMC: 6296157. DOI: 10.1186/s40409-018-0178-3.


References
1.
Lee S, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H . Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem. 1992; 267(36):25934-8. View

2.
Bon C . Synergism of the two subunits of crotoxin. Toxicon. 1982; 20(1):105-9. DOI: 10.1016/0041-0101(82)90173-8. View

3.
Vadas P, Hay J . Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock. Can J Physiol Pharmacol. 1983; 61(6):561-6. DOI: 10.1139/y83-086. View

4.
Salmon J . A radioimmunoassay for 6-keto-prostaglandin F1alpha. Prostaglandins. 1978; 15(3):383-97. DOI: 10.1016/0090-6980(78)90122-3. View

5.
Vadas P, Pruzanski W . Role of secretory phospholipases A2 in the pathobiology of disease. Lab Invest. 1986; 55(4):391-404. View